Titan Pharmaceuticals Inc (TTNP)

[Serenity3]

no no no.. you are far from insane .. my reference to Einstein's definition was specific to investor's perception of TTNP management doing the same thing over and over without change... I note you are also looking at management w/a jaundiced eye..

I do agree that Probuphine is a challenge BC of the regulatory hurdles.. but I think Clean Slate has a chance of success.. though, again the uncertainty over ACA (Anthem pulling out of Ohio) casts a cloud over the market... no cloud even in sight in California... 6th largest economy in the world and we're going our own way ... sizable opportunity for Clean Slate & Braeburn.. the tack w/insurance companies is to demonstrate the cost-effectiveness of treatment w/MAT as opposed to ER admissions for OD, over and over again... every 1st responder Naloxone intervention probably bills > than 2G & ER visit can bill between $10,000 to $30,000... it's < expensive to pay for evidenced based treatment... the faith-based programs are laudable but incomplete..search news ~ the social model treatment(no meds) facility in PA where 2 "counselors" were recently found dead from an overdose

As far as Proneura is concerned, TTNP has no time to waste as the patent expires June 2024 AND inventors will be nipping at their heels w/new implantables... that's why I'm advocating a management change sooner rather than later.. I'm still hanging on as I see some value here.. but I am keeping a close eye on the landscape.. thank you again and again for your postings